Depression drug related to ketamine wins endorsement of advisory panel

Depression drug related to ketamine wins endorsement of advisory panel

Depression drug related to ketamine wins endorsement of key advisory panel

By MEGAN THIELKING

DANIEL HULSHIZER/AP

The Johnson & Johnson drug was tested in combination with oral antidepressants as a therapy for treatment-resistant depression.

READ MORE